Cargando…
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
Treatment guidelines from the American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics state that stimulant medications have the most evidence for safety and efficacy in the treatment of childhood attention deficit hyperactivity disorder (ADHD). Longer-acting stimul...
Autores principales: | Domnitei, Diana, Madaan, Vishal |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877609/ https://www.ncbi.nlm.nih.gov/pubmed/20520740 |
Ejemplares similares
-
Update on optimal use of lisdexamfetamine in the treatment of ADHD
por: Madaan, Vishal, et al.
Publicado: (2013) -
New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Üçeyler, Nurcan, et al.
Publicado: (2008) -
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
por: Gold, Michael, et al.
Publicado: (2012) -
Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009) -
Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006)